Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析

◆英語タイトル:Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH227948FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nanjing Pharmaceutical Co Ltd (600713) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nanjing Pharmaceutical Co Ltd (NPC) focuses on the distribution of a wide range of pharmaceutical products and other products. It provides a range of pharmaceutical supply chain services and health chain services. NPC also provides traditional chinese medicine, logistics services and rent and property management. It offers its products to hospitals, pharmacies, community health institutions, chain pharmacies and rural township hospitals, clinics and other non-public medical institutions and commercial distribution enterprises. The company provides its services to Anhui, Jiangsu, Hubei, Sichuan, Yunnan and Fujian provinces covering several cities across China. NPC is headquartered in Nanjing, Jiangsu, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nanjing Pharmaceutical Co Ltd – Key Facts
Nanjing Pharmaceutical Co Ltd – Key Employees
Nanjing Pharmaceutical Co Ltd – Key Employee Biographies
Nanjing Pharmaceutical Co Ltd – Major Products and Services
Nanjing Pharmaceutical Co Ltd – History
Nanjing Pharmaceutical Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nanjing Pharmaceutical Co Ltd – Business Description
Business Segment: Main Business
Overview
Performance
Business Segment: Other Business
Overview
Performance
Geographical Segment: Anhui
Performance
Geographical Segment: Fujian
Performance
Geographical Segment: Hubei
Performance
Geographical Segment: Jiangsu
Performance
Geographical Segment: Other
Performance
Geographical Segment: Other Regions
Performance
Nanjing Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Nanjing Pharmaceutical Co Ltd – Strengths
Nanjing Pharmaceutical Co Ltd – Weaknesses
Nanjing Pharmaceutical Co Ltd – Opportunities
Nanjing Pharmaceutical Co Ltd – Threats
Nanjing Pharmaceutical Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Nanjing Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nanjing Pharmaceutical Co Ltd, Key Facts
Nanjing Pharmaceutical Co Ltd, Key Employees
Nanjing Pharmaceutical Co Ltd, Key Employee Biographies
Nanjing Pharmaceutical Co Ltd, Major Products and Services
Nanjing Pharmaceutical Co Ltd, History
Nanjing Pharmaceutical Co Ltd, Subsidiaries
Nanjing Pharmaceutical Co Ltd, Key Competitors
Nanjing Pharmaceutical Co Ltd, Ratios based on current share price
Nanjing Pharmaceutical Co Ltd, Annual Ratios
Nanjing Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Nanjing Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Nanjing Pharmaceutical Co Ltd, Interim Ratios
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Nanjing Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Procter & Gamble Co:戦略・SWOT・企業財務分析
    The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report Summary The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Deutsche Borse Ag:企業の戦略・SWOT・財務分析
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lakes Oil NL (LKO):企業の財務・戦略的SWOT分析
    Summary Lakes Oil NL (Lake Oil) is an upstream company that carries out exploration and production oil and gas. The company acquires, explores, and develops oil and natural gas properties. It operates Gippsland basin and Otway basin in Australia. Lake Oil offers re-processing and re-mapping of avail …
  • Al Jaber Group:企業の戦略・SWOT・財務分析
    Al Jaber Group - Strategy, SWOT and Corporate Finance Report Summary Al Jaber Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • China National Petroleum Corporation (CNPC):戦略・SWOT・企業財務分析
    China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Panasonic Corporation:企業の戦略・SWOT・財務分析
    Panasonic Corporation - Strategy, SWOT and Corporate Finance Report Summary Panasonic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Universal Health Services Inc (UHS):企業の財務・戦略的SWOT分析
    Universal Health Services Inc (UHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Richter Gedeon Nyrt (RICHTER)-医療機器分野:企業M&A・提携分析
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • Principia Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Principia Biopharma Inc (Principia Biopharma) is a biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase (BTK) inhibitor, Interleukin …
  • YTL Power International Bhd (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • University of Wollongong:企業の戦略的SWOT分析
    University of Wollongong - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Meezan Bank Ltd:企業の戦略・SWOT・財務情報
    Meezan Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Meezan Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • China Everbright Bank Co., Ltd.:戦略・SWOT・企業財務分析
    China Everbright Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Everbright Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Kodiak Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kodiak Sciences Inc (Kodiak Sciences), formerly Oligasis LLC, is a drug company that discovers and develops new medicines for the healthcare sector. The company provides retinal medicines for treatment of wet and dry forms of age-related macular degeneration. It utilizes its proprietary Bioc …
  • Glavbolgarstroy Holdings AD:企業の戦略・SWOT・財務情報
    Glavbolgarstroy Holdings AD - Strategy, SWOT and Corporate Finance Report Summary Glavbolgarstroy Holdings AD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務分析
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Longfor Properties Co., Ltd.:戦略・SWOT・企業財務分析
    Longfor Properties Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Longfor Properties Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aspyrian Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aspyrian Therapeutics Inc (Aspyrian Therapeutics) is a biotechnology company which develops precision targeted medicines to handle both the primary tumor and systemic disease. Its lead pipeline product, RM-1929, is under development for the treatment of different cancer types, including canc …
  • San Juan Basin Royalty Trust (SJT):企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding royalty i …
  • Nidec Corporation:戦略・SWOT・企業財務分析
    Nidec Corporation - Strategy, SWOT and Corporate Finance Report Summary Nidec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆